These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 30069716)
21. Therapeutic outcomes of transsphenoidal surgery in pediatric patients with craniopharyngiomas: a single-center study. Yamada S; Fukuhara N; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Inoshita N; Ito J J Neurosurg Pediatr; 2018 Jun; 21(6):549-562. PubMed ID: 29600905 [TBL] [Abstract][Full Text] [Related]
22. Concurrent Radiation and Targeted Therapy for Papillary Craniopharyngioma: A Case Report. Shah SN; Kaki PC; Shah SS; Shah SA Cureus; 2023 Jun; 15(6):e40190. PubMed ID: 37431357 [TBL] [Abstract][Full Text] [Related]
23. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases. Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Suri V; Sarkar C; Jagdevan A; Sharma BS; Sharma MC J Neurooncol; 2017 Jul; 133(3):487-495. PubMed ID: 28500561 [TBL] [Abstract][Full Text] [Related]
24. Craniopharyngioma in Pediatrics and Adults. Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943 [TBL] [Abstract][Full Text] [Related]
25. A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas. Fujio S; Juratli TA; Arita K; Hirano H; Nagano Y; Takajo T; Yoshimoto K; Bihun IV; Kaplan AB; Nayyar N; Fink AL; Bertalan MS; Tummala SS; Curry WT; Jones PS; Martinez-Lage M; Cahill DP; Barker FG; Brastianos PK Neurosurgery; 2019 Aug; 85(2):204-210. PubMed ID: 30481321 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy. Martinez-Gutierrez JC; D'Andrea MR; Cahill DP; Santagata S; Barker FG; Brastianos PK Neurosurg Focus; 2016 Dec; 41(6):E2. PubMed ID: 27903124 [TBL] [Abstract][Full Text] [Related]
28. [Craniopharyngiomas: The Dawn of a New Era with the Elucidation of Driver Genes]. Fujio S; Hanaya R No Shinkei Geka; 2023 Sep; 51(5):917-928. PubMed ID: 37743344 [TBL] [Abstract][Full Text] [Related]
29. Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells. Marucci G; de Biase D; Zoli M; Faustini-Fustini M; Bacci A; Pasquini E; Visani M; Mazzatenta D; Frank G; Tallini G Pituitary; 2015 Dec; 18(6):905-11. PubMed ID: 26156055 [TBL] [Abstract][Full Text] [Related]
30. Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma. Lin AL; Tabar V; Young RJ; Geer EB Pituitary; 2023 Aug; 26(4):482-487. PubMed ID: 37428397 [TBL] [Abstract][Full Text] [Related]
31. Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics. Robinson LC; Santagata S; Hankinson TC Neurosurg Focus; 2016 Dec; 41(6):E3. PubMed ID: 27903126 [TBL] [Abstract][Full Text] [Related]
32. Case Report: Successful Use of BRAF/MEK Inhibitors in Aggressive BRAF-mutant Craniopharyngioma. Wu ZP; Wang YL; Wang LC; Liu ZY; Fan RR; Zan X; Liang RC; Yang JL; Zhou LX; Xu JG World Neurosurg; 2023 Dec; 180():e117-e126. PubMed ID: 37683921 [TBL] [Abstract][Full Text] [Related]
33. Craniopharyngiomas: Challenges and Controversies. Asha MJ; Oswari S; Takami H; Velasquez C; Almeida JP; Gentili F World Neurosurg; 2020 Oct; 142():593-600. PubMed ID: 32987615 [TBL] [Abstract][Full Text] [Related]
34. [Molecularly Targeted Therapy for Craniopharyngioma]. Tanaka S; Takayanagi S; Takami H; Saito N No Shinkei Geka; 2022 Jan; 50(1):171-178. PubMed ID: 35169097 [TBL] [Abstract][Full Text] [Related]
36. Diagnosis and Management of Pediatric Papillary Craniopharyngiomas. Zhao C; Zhou Z; Zhang Y; Qi X; Wang X; Lin D; Liu H; Wang Y; Weng C; Chen J; Hu W; Liao L; Lin Z World Neurosurg; 2022 Sep; 165():e148-e158. PubMed ID: 35660482 [TBL] [Abstract][Full Text] [Related]
37. Pituitary Adenoma and Papillary Craniopharyngioma: A Rare Case of Collision Tumor and Review of the Literature. Bteich F; El Khoury L; Nohra G; Trak V; Yazbek S; Akiki M World Neurosurg; 2020 Jul; 139():63-69. PubMed ID: 32298831 [TBL] [Abstract][Full Text] [Related]
38. Craniopharyngioma-An update on metabolic and cognitive complications and new therapy. Erfurth EM J Intern Med; 2023 Sep; 294(3):269-280. PubMed ID: 37424210 [TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm. Calvanese F; Jacquesson T; Manet R; Vasiljevic A; Lasolle H; Ducray F; Raverot G; Jouanneau E Front Endocrinol (Lausanne); 2022; 13():882381. PubMed ID: 35757402 [TBL] [Abstract][Full Text] [Related]
40. First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: Case report and illustrative review. De Rosa A; Calvanese F; Ducray F; Vasiljevic A; Manet R; Raverot G; Jouanneau E Ann Endocrinol (Paris); 2023 Dec; 84(6):727-733. PubMed ID: 37865272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]